Moneycontrol
Get App
Last Updated : Apr 30, 2020 10:34 AM IST | Source: Moneycontrol.com

Morepen Labs share price jumps 5% after UK standards body certifies company's Himachal unit

The stock surged over 100 percent in the last 1 month. There were pending buy orders of 299 shares, with no sellers available.

Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?
Q. The Drug controller general of India has allowed restricted use of Kaletra the combination of medications lopinavir and ritonavir, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same. Use of Kaletra was allowed based on the fact that previous studies suggested Kaletra, as effective in preventing SARS from maturing and replicating. It has already achieved good results in China and Japan in curing Coronavirus. What was Lopinavir and Ritonavir originally used for?
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

The share price of Morepen Laboratories jumped 5 percent in morning trade on April 30 after the company received certification from BSI (British Standards Institution, UK) for its medical devices manufacturing facility at Baddi (Himachal Pradesh).

The stock has almost doubled over the last month and was quoting at Rs 18.65, up Rs 0.88, or 4.95 percent at 09:45 hours. There were pending buy orders of 299 shares, with no sellers.

Capture

Close

Morepen Laboratories has received the prestigious ISO-13485 certification from BSI (British Standards Institution, UK) for its state-of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh). The certification has been awarded for the manufacturing, distribution and aftersales service of all point-of-care diagnostic medical devices and their accessories manufactured at the company’s facility in Baddi, the company said in a filing to the exchanges.

Experts rigorously audited the manufacturing facility and management systems, and the company was awarded the certification based on the comprehensive audit procedures undertaken by the notified body, it added.

"This ISO-13485 certification opens new vistas for Morepen to export its diagnostic devices to various countries across the globe and also to seek CE (Conformité Européene) Certification for the European Union. Having complied with all the important technical and regulatory guidelines for the Quality Management Systems as per ISO-13485, the company is confident of securing CE certification for its products as a next step," said Sushil Suri, Chairman and Managing Director, Morepen Laboratories.

Earlier this month, the company received the license to manufacture Hydroxychloroquine (HCQ) from State Drug Controller, (HP) for its Baddi plant in Himachal Pradesh.

Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

First Published on Apr 30, 2020 10:34 am
Sections
Follow us on